TRANSCATHETER AORTIC VALVE REPLACEMENT
Clinical trials for TRANSCATHETER AORTIC VALVE REPLACEMENT explained in plain language.
Never miss a new study
Get alerted when new TRANSCATHETER AORTIC VALVE REPLACEMENT trials appear
Sign up with your email to follow new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cheap arthritis pill prevent deadly clots after heart valve replacement?
Disease control Not yet recruitingThis study tests whether a daily low-dose anti-inflammatory drug (colchicine) can prevent blood clots from forming on replacement heart valves after a minimally invasive valve procedure (TAVR). About 116 people who have had TAVR will either receive colchicine plus standard care o…
Matched conditions: TRANSCATHETER AORTIC VALVE REPLACEMENT
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
No X-Ray, no dye: new heart valve procedure could spare patients harmful exposure
Disease control Not yet recruitingThis study tests a new way to replace the aortic valve in people with a leaky heart valve (aortic regurgitation) without using X-rays or contrast dye. Instead, doctors will rely on ultrasound (TEE) to guide the procedure. The goal is to see if this approach is safe and effective,…
Matched conditions: TRANSCATHETER AORTIC VALVE REPLACEMENT
Phase: NA • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can a simple fluid prevent dangerous drops in blood pressure during heart surgery?
Symptom relief Not yet recruitingThis study tests whether giving a special fluid (colloid) before anesthesia can prevent blood pressure drops in 116 people undergoing transcatheter aortic valve replacement (TAVR). Participants will receive either the colloid or a standard salt solution before anesthesia. The goa…
Matched conditions: TRANSCATHETER AORTIC VALVE REPLACEMENT
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC